C86.31
Subcutaneous panniculitis-like T-cell lymphoma, in remission
Clinical Classification Guidelines
Medical Intelligence & Overview
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare type of skin cancer that originates in T-cells, a kind of white blood cell involved in immune responses. When diagnosed as 'in remission,' it indicates that the disease has decreased or disappeared following treatment, and signs or symptoms are no longer apparent. This condition primarily affects the fatty tissue beneath the skin, often forming nodules or lumps. While SPTCL can be aggressive, remission offers a positive outlook with ongoing monitoring and care.
Causes & Symptoms
Clinical Causes: The precise cause of SPTCL remains unclear, but it involves abnormal growth of T-cells in the fatty tissue beneath the skin. It is believed to be related to genetic mutations affecting immune cells. Environmental factors and immune system dysregulation may contribute to the development of this lymphoma.
Key Symptoms: Painless, firm nodules or lumps under the skin, often on the limbs or trunk. Localized swelling or redness around the affected areas. Possible ulceration or skin breakdown over nodules. Less commonly, systemic symptoms such as fever or weight loss may occur in active disease phases. In remission, these symptoms are typically not present.
Diagnostic & Treatment
Diagnosis Path: - Blood tests to assess overall immune function and rule out other conditions.
Treatment Protocols: - In cases achieving remission, continued follow-up and monitoring are essential to detect any signs of recurrence.
Clinical Advice & FAQs
Billing Guidance
Is C86.31 a billable ICD-10 code?
Yes, C86.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C86.31?
Clinical documentation must specify the nature of Subcutaneous panniculitis-like T-cell lymphoma, in remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference